{"id":"https://genegraph.clinicalgenome.org/r/8087e9c7-7398-4289-b075-7e206d890801v1.1","type":"EvidenceStrengthAssertion","dc:description":"*UMOD* was first reported in relation to autosomal dominant tubulointerstitial kidney disease (ADTKD) in 2002 (Hart et al., PMID 12471200). ADTKD due to *UMOD* pathogenic variants (ADTKD-*UMOD*) is diagnosed in individuals with a family history of chronic kidney disease leading to end stage kidney disease (ESKD), with little to no protein or blood in the urine. Hyperuricemia and gout may also be associated with family history. ADTKD-*UMOD* has been reported in the literature under the names familial juvenile hyperuricemic nephropathy type 1 and medullary cystic kidney disease type 2 (PMID 25738250). At least 125 unique variants (including missense, in-frame indel, and in-frame deletions) have been reported in humans with 97% of pathogenic variants clustering in exons 3 and 4 (PMID 32450155, PMID 32954071). Evidence supporting this gene-disease relationship includes case-level data, segregation data and experimental data. \nSummary of Case Level Data: Variants in this gene have been reported in at least 19 individuals (PMID 12471200, PMID 12629136, PMID 12900848, PMID 1451790, PMID 14570709 PMID 32954071). Variants in this gene segregated with disease in 83 additional family members. The mechanism for disease is heterozygous toxic gain of function (PMID 14570709, PMID 16883323, PMID 28990932) with experimental evidence suggesting mutant UMOD is retained in the endoplasmic reticulum, the stress inducing the unfolded protein response (UPR), leading to tubular cell atrophy.\nSummary of Experimental Evidence: This gene-disease association is supported by expression studies in patient kidney biopsies, urine and serum, in vitro functional alteration studies, and mouse models (PMID 14570709, PMID 16883323, PMID 27729211, PMID 28990932, PMID 32926855, PMID 32954071).\nIn summary, *UMOD* is definitively associated with autosomal dominant tubulointerstitial kidney disease. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Kidney Cystic and Ciliopathy Disorders GCEP Working Group on 01/13/2021 (SOP Version 8).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/8087e9c7-7398-4289-b075-7e206d890801","GCISnapshot":"https://genegraph.clinicalgenome.org/r/39233b4e-a491-47b4-8407-2e15dda89221","calculatedEvidenceStrength":"Definitive","changes":[{"id":"cg:summaryChange"},{"id":"cg:otherTextChange"}],"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/39233b4e-a491-47b4-8407-2e15dda89221_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10066","date":"2021-01-13T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/39233b4e-a491-47b4-8407-2e15dda89221_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10066","date":"2022-10-11T13:09:51.717Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/39233b4e-a491-47b4-8407-2e15dda89221_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a62433a6-3dd1-41eb-8250-728880c1a891","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a62433a6-3dd1-41eb-8250-728880c1a891_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12900848","allele":{"id":"https://genegraph.clinicalgenome.org/r/e9fca443-794a-48b8-8e23-fb254b3fe644","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"ENST00000396138.8(UMOD):c.815G>A (p.Cys272Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA394985157"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/d0f2e724-4645-4924-8966-63c836e0e578","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d0f2e724-4645-4924-8966-63c836e0e578_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14570709","allele":{"id":"https://genegraph.clinicalgenome.org/r/b2c1ef6f-0d73-4557-b09e-fb272004e952","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003361.3(UMOD):c.943T>C (p.Cys315Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA256254"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/1f5c5d1d-c1c7-4c64-b1d6-28bbc487c67a","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1f5c5d1d-c1c7-4c64-b1d6-28bbc487c67a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12629136","allele":{"id":"https://genegraph.clinicalgenome.org/r/7ad89c29-b6e2-4e43-951a-1330e85880ae","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003361.3(UMOD):c.230G>A (p.Cys77Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA256244"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/ccfb463f-8b12-4c86-aa02-018fe4ebb633","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ccfb463f-8b12-4c86-aa02-018fe4ebb633_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32954071","allele":{"id":"https://genegraph.clinicalgenome.org/r/1ad783fd-421c-4373-9879-65f5cd43c55d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003361.4(UMOD):c.529_555del (p.His177_Arg185del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA494097010"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/67d74242-a61b-4129-a7a4-f6900905b58b","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/67d74242-a61b-4129-a7a4-f6900905b58b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12629136","allele":{"id":"https://genegraph.clinicalgenome.org/r/d1cce108-24b0-476e-8d39-ad5851671bac","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003361.3(UMOD):c.383A>G (p.Asn128Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA256248"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/72c2bfa9-ef89-48b0-8654-4d7b51d9e600","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/72c2bfa9-ef89-48b0-8654-4d7b51d9e600_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14531790","allele":{"id":"https://genegraph.clinicalgenome.org/r/b7890751-7beb-4d71-a5b3-4a9692a672fe","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003361.3(UMOD):c.744C>G (p.Cys248Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10605900"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/f2edf8d8-0b64-43d7-a30d-4beb59f26e94","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f2edf8d8-0b64-43d7-a30d-4beb59f26e94_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12471200","allele":{"id":"https://genegraph.clinicalgenome.org/r/76a7f846-4b17-4c92-bfa8-88ea04e494f4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003361.3(UMOD):c.443G>A (p.Cys148Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA256238"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/ac5db391-98e8-4fd7-9de6-cab7fa4cc244","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac5db391-98e8-4fd7-9de6-cab7fa4cc244_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14570709","allele":{"id":"https://genegraph.clinicalgenome.org/r/5e891ed1-8171-4050-9e20-b7bf94d48a66","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"ENST00000396138.8(UMOD):c.595T>A (p.Cys199Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA394985936"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/71f12459-2828-430a-a33a-e917877f7bf4","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/71f12459-2828-430a-a33a-e917877f7bf4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14531790","allele":{"id":"https://genegraph.clinicalgenome.org/r/480800e9-179c-4eda-af55-0f08f9f33f33","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"ENST00000396138.8(UMOD):c.821C>A (p.Thr274Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA394985136"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/17439528-ec06-4451-8107-e8c444e6482d","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/17439528-ec06-4451-8107-e8c444e6482d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12471200","allele":{"id":"https://genegraph.clinicalgenome.org/r/054ea881-010d-48f9-ab19-460c3b8e95de","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003361.3(UMOD):c.649T>C (p.Cys217Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA256240"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/f26bd4d3-3d77-4b13-8388-05a89954f754","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f26bd4d3-3d77-4b13-8388-05a89954f754_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14570709","allele":{"id":"https://genegraph.clinicalgenome.org/r/f1f1e232-922c-46a3-bdac-732fb9897d01","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"ENST00000396138.8(UMOD):c.591T>G (p.Cys197Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA394985947"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/a0c2dab1-78c8-4729-a73c-3285f264ba19","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a0c2dab1-78c8-4729-a73c-3285f264ba19_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12629136","allele":{"id":"https://genegraph.clinicalgenome.org/r/ce7786ca-b883-428b-b207-1ef5e9968f9b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003361.3(UMOD):c.898T>G (p.Cys300Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA256252"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/a0c2dab1-78c8-4729-a73c-3285f264ba19_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Confirmed with restriction endonuclease analysis","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/39233b4e-a491-47b4-8407-2e15dda89221_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b89e027a-27e4-4745-9f6b-07d55180f5c6_proband_segregation","type":"FamilyCosegregation","dc:description":"Not enough family information available","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12629136","rdfs:label":"13/00","family":{"id":"https://genegraph.clinicalgenome.org/r/b89e027a-27e4-4745-9f6b-07d55180f5c6","type":"Family","rdfs:label":"13/00","member":{"id":"https://genegraph.clinicalgenome.org/r/28f84a69-0308-4aae-9971-53ca059190b8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12629136","rdfs:label":"2_turner","allele":{"id":"https://genegraph.clinicalgenome.org/r/3ee5a3e9-8b8c-414b-921d-ac7e6e3239ae","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003361.3(UMOD):c.376T>C (p.Cys126Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA256246"}},"detectionMethod":"Using known linkage region for FJHN gene, kidney expressed genes were identified. Exome sequencing for these 13 genes was performed. Variant confirmation was performed by either restriction endonuclease analysis or allele specific oligonucleotide hybridization.","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002149","obo:HP_0001997","obo:HP_0000083","obo:HP_0000006","obo:HP_0012622"],"previousTesting":false,"secondTestingMethod":"Restriction digest","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/41e6f509-f74d-43b6-8f40-9e9cccb5a9eb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12629136","allele":{"id":"https://genegraph.clinicalgenome.org/r/3ee5a3e9-8b8c-414b-921d-ac7e6e3239ae"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0000083","obo:HP_0000006","obo:HP_0002149","obo:HP_0001997","obo:HP_0012622"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/28f84a69-0308-4aae-9971-53ca059190b8"}},{"id":"https://genegraph.clinicalgenome.org/r/aac230ab-e895-4fe9-b639-e90939f48a5e_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14570709","rdfs:label":"MCKD#7","estimatedLodScore":4.52,"family":{"id":"https://genegraph.clinicalgenome.org/r/aac230ab-e895-4fe9-b639-e90939f48a5e","type":"Family","rdfs:label":"MCKD#7","member":{"id":"https://genegraph.clinicalgenome.org/r/7dc016b7-6d2c-442e-9493-f0126cd5a66b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14570709","rdfs:label":"2_Rampoldi ","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":50,"allele":{"id":"https://genegraph.clinicalgenome.org/r/5e891ed1-8171-4050-9e20-b7bf94d48a66"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Clinical criteria: (a) history of renal insufficiency with inheritance compatible with an autosomal dominant trait; (b) stable low urinary osmolality in the first morning urine and lack of any compensatory effect after endonasal Minirin (two pushes); (c) history of gout and hyperuricemia (serum uric acid >6 mg%) due to low fractional excretion of uric acid (<5%). In the absence of a clear history of gout, hyperuricemia was defined as a serum level of uric acid higher than one standard deviation of the normal values for age and sex; (d) renal biopsy showing tubulo-interstitial fibrosis with infiltrates, tubular atrophy and thickening of the tubular basal membrane with periodic acid Schiff-positive material. ","phenotypes":["obo:HP_0001997","obo:HP_0000083","obo:HP_0002149","obo:HP_0012622","obo:HP_0000006"],"previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ac5db391-98e8-4fd7-9de6-cab7fa4cc244_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Clinical criteria: (a) history of renal insufficiency with inheritance compatible with an autosomal dominant trait; (b) stable low urinary osmolality in the first morning urine and lack of any compensatory effect after endonasal Minirin (two pushes); (c) history of gout and hyperuricemia (serum uric acid >6 mg%) due to low fractional excretion of uric acid (<5%). In the absence of a clear history of gout, hyperuricemia was defined as a serum level of uric acid higher than one standard deviation of the normal values for age and sex; (d) renal biopsy showing tubulo-interstitial fibrosis with infiltrates, tubular atrophy and thickening of the tubular basal membrane with periodic acid Schiff-positive material. ","phenotypePositiveAllelePositive":16,"phenotypes":["obo:HP_0000083","obo:HP_0000006","obo:HP_0012622","obo:HP_0001997","obo:HP_0002149"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/7dc016b7-6d2c-442e-9493-f0126cd5a66b"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/b5189444-a979-4c6f-8d0d-cac3dd6605be_proband_segregation","type":"FamilyCosegregation","dc:description":"Not enough family information available","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14570709","rdfs:label":"MCKD#9","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/b5189444-a979-4c6f-8d0d-cac3dd6605be","type":"Family","rdfs:label":"MCKD#9","member":{"id":"https://genegraph.clinicalgenome.org/r/61e0c122-b60f-4db1-bbfc-6916911ed08c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14570709","rdfs:label":"3_Rampoldi ","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":17,"allele":{"id":"https://genegraph.clinicalgenome.org/r/f1f1e232-922c-46a3-bdac-732fb9897d01"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Clinical criteria: (a) history of renal insufficiency with inheritance compatible with an autosomal dominant trait; (b) stable low urinary osmolality in the first morning urine and lack of any compensatory effect after endonasal Minirin (two pushes); (c) history of gout and hyperuricemia (serum uric acid >6 mg%) due to low fractional excretion of uric acid (<5%). In the absence of a clear history of gout, hyperuricemia was defined as a serum level of uric acid higher than one standard deviation of the normal values for age and sex; (d) renal biopsy showing tubulo-interstitial fibrosis with infiltrates, tubular atrophy and thickening of the tubular basal membrane with periodic acid Schiff-positive material. lies described in PMID:8427538. Unknown which of the 2 families it is.","phenotypes":["obo:HP_0001997","obo:HP_0002149","obo:HP_0012622","obo:HP_0000083","obo:HP_0000006"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/f26bd4d3-3d77-4b13-8388-05a89954f754_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Clinical criteria: (a) history of renal insufficiency with inheritance compatible with an autosomal dominant trait; (b) stable low urinary osmolality in the first morning urine and lack of any compensatory effect after endonasal Minirin (two pushes); (c) history of gout and hyperuricemia (serum uric acid >6 mg%) due to low fractional excretion of uric acid (<5%). In the absence of a clear history of gout, hyperuricemia was defined as a serum level of uric acid higher than one standard deviation of the normal values for age and sex; (d) renal biopsy showing tubulo-interstitial fibrosis with infiltrates, tubular atrophy and thickening of the tubular basal membrane with periodic acid Schiff-positive material. lies described in PMID:8427538. Unknown which of the 2 families it is.","phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0001997","obo:HP_0002149","obo:HP_0000083","obo:HP_0012622","obo:HP_0000006"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/61e0c122-b60f-4db1-bbfc-6916911ed08c"}},{"id":"https://genegraph.clinicalgenome.org/r/527f1a7e-b536-45ca-9f17-3fceb0d24380_proband_segregation","type":"FamilyCosegregation","dc:description":"Not enough family information available","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12629136","rdfs:label":"11/00","family":{"id":"https://genegraph.clinicalgenome.org/r/527f1a7e-b536-45ca-9f17-3fceb0d24380","type":"Family","rdfs:label":"11/00","member":{"id":"https://genegraph.clinicalgenome.org/r/8044ca1a-d927-4adb-98e9-6cc00f8af160","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12629136","rdfs:label":"1_turner","allele":{"id":"https://genegraph.clinicalgenome.org/r/7ad89c29-b6e2-4e43-951a-1330e85880ae"},"detectionMethod":"Other: Allele specific oligonucleotide hybridization.\n\nUsing known linkage region for FJHN gene, kidney expressed genes were identified. Exome sequencing for these 13 genes was performed. Variant confirmation was performed by either restriction endonuclease analysis or allele specific oligonucleotide hybridization.\n","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0012622","obo:HP_0000083","obo:HP_0002149","obo:HP_0000006","obo:HP_0001997"],"previousTesting":false,"secondTestingMethod":"Other","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/1f5c5d1d-c1c7-4c64-b1d6-28bbc487c67a_variant_evidence_item"}}},"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0012622","obo:HP_0001997","obo:HP_0000083","obo:HP_0000006","obo:HP_0002149"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/8044ca1a-d927-4adb-98e9-6cc00f8af160"}},{"id":"https://genegraph.clinicalgenome.org/r/82cfa11b-e279-445c-8417-505e584d043d_proband_segregation","type":"FamilyCosegregation","dc:description":"Not enough family information available","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14570709","rdfs:label":"GCKD#1","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/82cfa11b-e279-445c-8417-505e584d043d","type":"Family","rdfs:label":"GCKD#1","member":{"id":"https://genegraph.clinicalgenome.org/r/625371b0-cc66-4ff1-9c3a-43489cc13a34","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14570709","rdfs:label":"4_Rampoldi ","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":12,"allele":{"id":"https://genegraph.clinicalgenome.org/r/b2c1ef6f-0d73-4557-b09e-fb272004e952"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Clinical criteria: (a) history of renal insufficiency with inheritance compatible with an autosomal dominant trait; (b) stable low urinary osmolality in the first morning urine and lack of any compensatory effect after endonasal Minirin (two pushes); (c) history of gout and hyperuricemia (serum uric acid >6 mg%) due to low fractional excretion of uric acid (<5%). In the absence of a clear history of gout, hyperuricemia was defined as a serum level of uric acid higher than one standard deviation of the normal values for age and sex; (d) renal biopsy showing tubulo-interstitial fibrosis with infiltrates, tubular atrophy and thickening of the tubular basal membrane with periodic acid Schiff-positive material. lies described in PMID:8427538. Unknown which of the 2 families it is.","phenotypes":["obo:HP_0002149","obo:HP_0012622","obo:HP_0001997","obo:HP_0000083","obo:HP_0000006"],"previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d0f2e724-4645-4924-8966-63c836e0e578_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Clinical criteria: (a) history of renal insufficiency with inheritance compatible with an autosomal dominant trait; (b) stable low urinary osmolality in the first morning urine and lack of any compensatory effect after endonasal Minirin (two pushes); (c) history of gout and hyperuricemia (serum uric acid >6 mg%) due to low fractional excretion of uric acid (<5%). In the absence of a clear history of gout, hyperuricemia was defined as a serum level of uric acid higher than one standard deviation of the normal values for age and sex; (d) renal biopsy showing tubulo-interstitial fibrosis with infiltrates, tubular atrophy and thickening of the tubular basal membrane with periodic acid Schiff-positive material. lies described in PMID:8427538. Unknown which of the 2 families it is.","phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0000006","obo:HP_0012622","obo:HP_0000083","obo:HP_0001997","obo:HP_0002149"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/625371b0-cc66-4ff1-9c3a-43489cc13a34"}},{"id":"https://genegraph.clinicalgenome.org/r/9e4e92c1-f607-4d1a-86b4-5a5f2c5062ae_proband_segregation","type":"FamilyCosegregation","dc:description":"Not enough family information available","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12900848","rdfs:label":"Family 1","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/9e4e92c1-f607-4d1a-86b4-5a5f2c5062ae","type":"Family","rdfs:label":"Family 1","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/1c823a29-680a-4fe1-aaff-f900ea3a5297","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12900848","rdfs:label":"1_bleyer","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":12,"allele":{"id":"https://genegraph.clinicalgenome.org/r/e9fca443-794a-48b8-8e23-fb254b3fe644"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0002149","obo:HP_0000006","obo:HP_0012622","obo:HP_0000083","obo:HP_0001997"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/a62433a6-3dd1-41eb-8250-728880c1a891_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0000006","obo:HP_0000083","obo:HP_0012622","obo:HP_0002149","obo:HP_0001997"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/1c823a29-680a-4fe1-aaff-f900ea3a5297"}},{"id":"https://genegraph.clinicalgenome.org/r/e26fc2cf-c8fa-4d4a-adcb-000389fa991f_proband_segregation","type":"FamilyCosegregation","dc:description":"Not enough segregations","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14531790","rdfs:label":"F524","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/e26fc2cf-c8fa-4d4a-adcb-000389fa991f","type":"Family","rdfs:label":"F524","member":{"id":"https://genegraph.clinicalgenome.org/r/95effa98-0592-4912-88ae-d71fec8ecd65","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14531790","rdfs:label":"1_Wolf ","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":27,"allele":{"id":"https://genegraph.clinicalgenome.org/r/480800e9-179c-4eda-af55-0f08f9f33f33"},"firstTestingMethod":"Linkage analysis","phenotypeFreeText":"1) autosomal-dominant inheritance, (2) chronic renal failure, (3) defective urine concentration with polyuria, (4) at least one pedigree member with chronic renal failure in whom renal biopsy showed tubulointerstitial fibrosis with infiltrates, tubular atrophy, and thickening of the tubular basement membrane. Optional clinical criteria were normal or small-sized kidneys with occasional small corticomedullary cysts.\n","phenotypes":["obo:HP_0002149","obo:HP_0000006","obo:HP_0001997","obo:HP_0012622","obo:HP_0000083"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/71f12459-2828-430a-a33a-e917877f7bf4_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"1) autosomal-dominant inheritance, (2) chronic renal failure, (3) defective urine concentration with polyuria, (4) at least one pedigree member with chronic renal failure in whom renal biopsy showed tubulointerstitial fibrosis with infiltrates, tubular atrophy, and thickening of the tubular basement membrane. Optional clinical criteria were normal or small-sized kidneys with occasional small corticomedullary cysts.\n","phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0001997","obo:HP_0012622","obo:HP_0000006","obo:HP_0002149","obo:HP_0000083"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/95effa98-0592-4912-88ae-d71fec8ecd65"}},{"id":"https://genegraph.clinicalgenome.org/r/b6588f1a-59d1-4218-893d-c3fa07ed5a38_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14531790","rdfs:label":"F762","estimatedLodScore":1.51,"family":{"id":"https://genegraph.clinicalgenome.org/r/b6588f1a-59d1-4218-893d-c3fa07ed5a38","type":"Family","rdfs:label":"F762","member":{"id":"https://genegraph.clinicalgenome.org/r/431eb5f8-d208-46ee-a07f-00e84b340cb1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14531790","rdfs:label":"3_Wolf ","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":59,"allele":{"id":"https://genegraph.clinicalgenome.org/r/89908c83-2667-476d-a410-ad79adcb1a1f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001008389.3(UMOD):c.278_289delinsCCGCCTCCT (p.Val93_Gly97delinsAlaAlaSerCys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10583988"}},"firstTestingMethod":"Linkage analysis","phenotypeFreeText":"1) autosomal-dominant inheritance, (2) chronic renal failure, (3) defective urine concentration with polyuria, (4) at least one pedigree member with chronic renal failure in whom renal biopsy showed tubulointerstitial fibrosis with infiltrates, tubular atrophy, and thickening of the tubular basement membrane. Optional clinical criteria were normal or small-sized kidneys with occasional small corticomedullary cysts.\n","phenotypes":["obo:HP_0000006","obo:HP_0001997","obo:HP_0002149","obo:HP_0012622","obo:HP_0000083"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/393763a2-b27a-4c06-80cf-18d2ec72683b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14531790","allele":{"id":"https://genegraph.clinicalgenome.org/r/89908c83-2667-476d-a410-ad79adcb1a1f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"1) autosomal-dominant inheritance, (2) chronic renal failure, (3) defective urine concentration with polyuria, (4) at least one pedigree member with chronic renal failure in whom renal biopsy showed tubulointerstitial fibrosis with infiltrates, tubular atrophy, and thickening of the tubular basement membrane. Optional clinical criteria were normal or small-sized kidneys with occasional small corticomedullary cysts.\n","phenotypePositiveAllelePositive":6,"phenotypes":["obo:HP_0002149","obo:HP_0012622","obo:HP_0001997","obo:HP_0000083","obo:HP_0000006"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/431eb5f8-d208-46ee-a07f-00e84b340cb1"},"publishedLodScore":3.75,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/95f454e1-48b6-4657-8b83-da67aaaf2e8b_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14570709","rdfs:label":"MCKD #1","estimatedLodScore":2.11,"family":{"id":"https://genegraph.clinicalgenome.org/r/95f454e1-48b6-4657-8b83-da67aaaf2e8b","type":"Family","rdfs:label":"MCKD #1","member":{"id":"https://genegraph.clinicalgenome.org/r/0dc4dd64-26da-40da-a46c-2dc687bffa53","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14570709","rdfs:label":"1_Rampoldi","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":54,"allele":{"id":"https://genegraph.clinicalgenome.org/r/68465d4a-e0f2-4cf0-9cef-215f4e0d020f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"ENST00000396138.8(UMOD):c.1097G>A (p.Cys366Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA394983697"}},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Clinical criteria: (a) history of renal insufficiency with inheritance compatible with an autosomal dominant trait; (b) stable low urinary osmolality in the first morning urine and lack of any compensatory effect after endonasal Minirin (two pushes); (c) history of gout and hyperuricemia (serum uric acid >6 mg%) due to low fractional excretion of uric acid (<5%). In the absence of a clear history of gout, hyperuricemia was defined as a serum level of uric acid higher than one standard deviation of the normal values for age and sex; (d) renal biopsy showing tubulo-interstitial fibrosis with infiltrates, tubular atrophy and thickening of the tubular basal membrane with periodic acid Schiff-positive material. ","phenotypes":["obo:HP_0000083","obo:HP_0002149","obo:HP_0012622","obo:HP_0000006","obo:HP_0001997"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/4bf3aff6-7859-40a3-9039-b62e0516824e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14570709","allele":{"id":"https://genegraph.clinicalgenome.org/r/68465d4a-e0f2-4cf0-9cef-215f4e0d020f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Clinical criteria: (a) history of renal insufficiency with inheritance compatible with an autosomal dominant trait; (b) stable low urinary osmolality in the first morning urine and lack of any compensatory effect after endonasal Minirin (two pushes); (c) history of gout and hyperuricemia (serum uric acid >6 mg%) due to low fractional excretion of uric acid (<5%). In the absence of a clear history of gout, hyperuricemia was defined as a serum level of uric acid higher than one standard deviation of the normal values for age and sex; (d) renal biopsy showing tubulo-interstitial fibrosis with infiltrates, tubular atrophy and thickening of the tubular basal membrane with periodic acid Schiff-positive material. ","phenotypePositiveAllelePositive":8,"phenotypes":["obo:HP_0000083","obo:HP_0000006","obo:HP_0012622","obo:HP_0001997","obo:HP_0002149"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/0dc4dd64-26da-40da-a46c-2dc687bffa53"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/77c3a28d-1d8f-4fdc-8ba2-2c34744455df_proband_segregation","type":"FamilyCosegregation","dc:description":"Not enough family information available","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12629136","rdfs:label":"13/96","family":{"id":"https://genegraph.clinicalgenome.org/r/77c3a28d-1d8f-4fdc-8ba2-2c34744455df","type":"Family","rdfs:label":"13/96","ethnicity":{"id":"cg:HispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/317e2fa5-9005-444f-b620-c09a9a357317","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12629136","rdfs:label":"4_turner","allele":{"id":"https://genegraph.clinicalgenome.org/r/81435bff-ab17-444b-b00c-2949c6363290","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003361.3(UMOD):c.764G>A (p.Cys255Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA256250"}},"detectionMethod":"Other: Allele specific oligonucleotide hybridization.\n\nUsing known linkage region for FJHN gene, kidney expressed genes were identified. Exome sequencing for these 13 genes was performed. Variant confirmation was performed by either restriction endonuclease analysis or allele specific oligonucleotide hybridization.\n","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0012622","obo:HP_0001997","obo:HP_0000006","obo:HP_0000083","obo:HP_0002149"],"previousTesting":false,"secondTestingMethod":"Other","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/23a3ee4f-053f-4463-b542-db3d6b6278a2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12629136","allele":{"id":"https://genegraph.clinicalgenome.org/r/81435bff-ab17-444b-b00c-2949c6363290"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0012622","obo:HP_0002149","obo:HP_0000083","obo:HP_0000006","obo:HP_0001997"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/317e2fa5-9005-444f-b620-c09a9a357317"}},{"id":"https://genegraph.clinicalgenome.org/r/6a2c24f4-2d41-4ac9-823f-9502296e4e80_proband_segregation","type":"FamilyCosegregation","dc:description":"Not enough segregations","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12471200","rdfs:label":"Family 3","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/6a2c24f4-2d41-4ac9-823f-9502296e4e80","type":"Family","rdfs:label":"Family 3","member":{"id":"https://genegraph.clinicalgenome.org/r/c088967a-0c3b-43c9-9c7c-c69bdb8ae662","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12471200","rdfs:label":"3_Hart","allele":{"id":"https://genegraph.clinicalgenome.org/r/176345d7-a5ce-4a35-a504-77f41fa04655","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003361.3(UMOD):c.307G>T (p.Gly103Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA256242"}},"detectionMethod":"GPRC5B and UMOD were identified and sequenced as candidate genes after linkage analysis.","firstTestingMethod":"Linkage analysis","phenotypes":["obo:HP_0000006","obo:HP_0001997","obo:HP_0012622","obo:HP_0000083","obo:HP_0002149"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/6ea165f8-4aaa-439b-8f7b-7493d124b16f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12471200","allele":{"id":"https://genegraph.clinicalgenome.org/r/176345d7-a5ce-4a35-a504-77f41fa04655"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0000006","obo:HP_0012622","obo:HP_0002149","obo:HP_0000083","obo:HP_0001997"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/c088967a-0c3b-43c9-9c7c-c69bdb8ae662"}},{"id":"https://genegraph.clinicalgenome.org/r/f2fc7c72-c311-438c-a489-9a14ca849ed5_proband_segregation","type":"FamilyCosegregation","dc:description":"Not enough segregations","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14531790","rdfs:label":"F739","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/f2fc7c72-c311-438c-a489-9a14ca849ed5","type":"Family","rdfs:label":"F739","member":{"id":"https://genegraph.clinicalgenome.org/r/bf712633-d1b3-436e-ac86-eb7b29116654","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14531790","rdfs:label":"2_Wolf ","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":39,"allele":{"id":"https://genegraph.clinicalgenome.org/r/b7890751-7beb-4d71-a5b3-4a9692a672fe"},"firstTestingMethod":"Linkage analysis","phenotypeFreeText":"1) autosomal-dominant inheritance, (2) chronic renal failure, (3) defective urine concentration with polyuria, (4) at least one pedigree member with chronic renal failure in whom renal biopsy showed tubulointerstitial fibrosis with infiltrates, tubular atrophy, and thickening of the tubular basement membrane. Optional clinical criteria were normal or small-sized kidneys with occasional small corticomedullary cysts.\n","phenotypes":["obo:HP_0002149","obo:HP_0001997","obo:HP_0000083","obo:HP_0012622","obo:HP_0000006"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/72c2bfa9-ef89-48b0-8654-4d7b51d9e600_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"1) autosomal-dominant inheritance, (2) chronic renal failure, (3) defective urine concentration with polyuria, (4) at least one pedigree member with chronic renal failure in whom renal biopsy showed tubulointerstitial fibrosis with infiltrates, tubular atrophy, and thickening of the tubular basement membrane. Optional clinical criteria were normal or small-sized kidneys with occasional small corticomedullary cysts.\n","phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0001997","obo:HP_0000083","obo:HP_0000006","obo:HP_0002149","obo:HP_0012622"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/bf712633-d1b3-436e-ac86-eb7b29116654"}},{"id":"https://genegraph.clinicalgenome.org/r/814b07f5-d17b-46d6-8433-3d0cb7ccd7a8_proband_segregation","type":"FamilyCosegregation","dc:description":"Not enough segregations in family","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12629136","rdfs:label":"20/96","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/814b07f5-d17b-46d6-8433-3d0cb7ccd7a8","type":"Family","rdfs:label":"20/96","ethnicity":{"id":"cg:HispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/6d1fe5d8-249c-4012-b793-83a2104753d8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12629136","rdfs:label":"5_turner","allele":{"id":"https://genegraph.clinicalgenome.org/r/ce7786ca-b883-428b-b207-1ef5e9968f9b"},"detectionMethod":"Using known linkage region for FJHN gene, kidney expressed genes were identified. Exome sequencing for these 13 genes was performed. Variant confirmation was performed by either restriction endonuclease analysis or allele specific oligonucleotide hybridization.","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001997","obo:HP_0002149","obo:HP_0000006","obo:HP_0000083","obo:HP_0012622"],"previousTesting":false,"secondTestingMethod":"Restriction digest","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/a0c2dab1-78c8-4729-a73c-3285f264ba19_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0001997","obo:HP_0012622","obo:HP_0002149","obo:HP_0000006","obo:HP_0000083"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/6d1fe5d8-249c-4012-b793-83a2104753d8"}},{"id":"https://genegraph.clinicalgenome.org/r/cea9f7ec-edad-4e93-bdec-936770163452_proband_segregation","type":"FamilyCosegregation","dc:description":"Not enough family information available","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12629136","rdfs:label":"1/96","family":{"id":"https://genegraph.clinicalgenome.org/r/cea9f7ec-edad-4e93-bdec-936770163452","type":"Family","rdfs:label":"1/96","ethnicity":{"id":"cg:HispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/4b59be2f-d520-4c29-9c69-47fede015689","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12629136","rdfs:label":"3_turner","allele":{"id":"https://genegraph.clinicalgenome.org/r/d1cce108-24b0-476e-8d39-ad5851671bac"},"detectionMethod":"Other: Allele specific oligonucleotide hybridization.\n\nUsing known linkage region for FJHN gene, kidney expressed genes were identified. Exome sequencing for these 13 genes was performed. Variant confirmation was performed by either restriction endonuclease analysis or allele specific oligonucleotide hybridization.\n","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000083","obo:HP_0002149","obo:HP_0012622","obo:HP_0001997","obo:HP_0000006"],"previousTesting":false,"secondTestingMethod":"Other","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/67d74242-a61b-4129-a7a4-f6900905b58b_variant_evidence_item"}}},"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0001997","obo:HP_0000006","obo:HP_0012622","obo:HP_0000083","obo:HP_0002149"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/4b59be2f-d520-4c29-9c69-47fede015689"}},{"id":"https://genegraph.clinicalgenome.org/r/f1edd397-2e52-4b42-8682-80428771a4ab_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12471200","rdfs:label":"Family 1","estimatedLodScore":10.54,"family":{"id":"https://genegraph.clinicalgenome.org/r/f1edd397-2e52-4b42-8682-80428771a4ab","type":"Family","rdfs:label":"Family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/37b9fff9-b3b9-4505-a2be-097bb001336f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12471200","rdfs:label":"1_Hart","allele":{"id":"https://genegraph.clinicalgenome.org/r/1ad783fd-421c-4373-9879-65f5cd43c55d"},"detectionMethod":"GPRC5B and UMOD were identified and sequenced as candidate genes after linkage analysis. ","firstTestingMethod":"Linkage analysis","phenotypes":["obo:HP_0000083","obo:HP_0000006","obo:HP_0012622","obo:HP_0002149","obo:HP_0001997"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/fae18afa-7049-4bb5-ac4d-3858bf6aa034_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12471200","allele":{"id":"https://genegraph.clinicalgenome.org/r/1ad783fd-421c-4373-9879-65f5cd43c55d"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":36,"phenotypes":["obo:HP_0002149","obo:HP_0000006","obo:HP_0001997","obo:HP_0000083","obo:HP_0012622"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/37b9fff9-b3b9-4505-a2be-097bb001336f"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/f7ef584f-a1cc-44a9-999d-ffb6fc3eb093_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12471200","rdfs:label":"Family 2","estimatedLodScore":2.41,"family":{"id":"https://genegraph.clinicalgenome.org/r/f7ef584f-a1cc-44a9-999d-ffb6fc3eb093","type":"Family","rdfs:label":"Family 2","member":{"id":"https://genegraph.clinicalgenome.org/r/90fa4145-7ce0-4266-839f-6e967949dfce","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12471200","rdfs:label":"2_Hart","allele":{"id":"https://genegraph.clinicalgenome.org/r/76a7f846-4b17-4c92-bfa8-88ea04e494f4"},"detectionMethod":"GPRC5B and UMOD were identified and sequenced as candidate genes after linkage analysis","firstTestingMethod":"Linkage analysis","phenotypes":["obo:HP_0000006","obo:HP_0000083","obo:HP_0012622","obo:HP_0002149","obo:HP_0001997"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/f2edf8d8-0b64-43d7-a30d-4beb59f26e94_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":9,"phenotypes":["obo:HP_0012622","obo:HP_0001997","obo:HP_0000006","obo:HP_0002149","obo:HP_0000083"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/90fa4145-7ce0-4266-839f-6e967949dfce"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/ff8a1f2f-4f1a-4867-a4a2-c57b6b7c096f_proband_segregation","type":"FamilyCosegregation","dc:description":"Only 1 person genotyped for family","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12471200","rdfs:label":"Family 4","family":{"id":"https://genegraph.clinicalgenome.org/r/ff8a1f2f-4f1a-4867-a4a2-c57b6b7c096f","type":"Family","rdfs:label":"Family 4","member":{"id":"https://genegraph.clinicalgenome.org/r/219050f0-a058-476d-add0-d4a7e8980c9d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12471200","rdfs:label":"4_Hart","allele":{"id":"https://genegraph.clinicalgenome.org/r/054ea881-010d-48f9-ab19-460c3b8e95de"},"detectionMethod":"GPRC5B and UMOD were identified and sequenced as candidate genes after linkage analysis.","firstTestingMethod":"Linkage analysis","phenotypes":["obo:HP_0012622","obo:HP_0002149","obo:HP_0001997","obo:HP_0000006","obo:HP_0000083"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/17439528-ec06-4451-8107-e8c444e6482d_variant_evidence_item"}}},"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0012622","obo:HP_0000006","obo:HP_0002149","obo:HP_0001997","obo:HP_0000083"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/219050f0-a058-476d-add0-d4a7e8980c9d"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/6ea165f8-4aaa-439b-8f7b-7493d124b16f","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6ea165f8-4aaa-439b-8f7b-7493d124b16f_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/080b842a-f4ce-494b-a5f1-7574f0e06f49","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/080b842a-f4ce-494b-a5f1-7574f0e06f49_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32954071","allele":{"id":"https://genegraph.clinicalgenome.org/r/b436a3eb-f5dc-474f-bcfd-15c33d74d19b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003361.4(UMOD):c.230G>C (p.Cys77Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA394987202"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/393763a2-b27a-4c06-80cf-18d2ec72683b","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/393763a2-b27a-4c06-80cf-18d2ec72683b_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/4bf3aff6-7859-40a3-9039-b62e0516824e","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4bf3aff6-7859-40a3-9039-b62e0516824e_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/23a3ee4f-053f-4463-b542-db3d6b6278a2","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/23a3ee4f-053f-4463-b542-db3d6b6278a2_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/fae18afa-7049-4bb5-ac4d-3858bf6aa034","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fae18afa-7049-4bb5-ac4d-3858bf6aa034_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/41e6f509-f74d-43b6-8f40-9e9cccb5a9eb","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/41e6f509-f74d-43b6-8f40-9e9cccb5a9eb_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":6.7},{"id":"https://genegraph.clinicalgenome.org/r/39233b4e-a491-47b4-8407-2e15dda89221_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/39233b4e-a491-47b4-8407-2e15dda89221_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f78dc92f-a2c2-4cad-9c55-42aa0aa72d68","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/146780e4-fbad-4486-8f55-510aeec7d03e","type":"Finding","dc:description":"Kidney biopsies stained for Uromodulin. Intracellular aggregates of mutant uromodulin in epithelial cells of thick ascending limb and distal convoluted tubules found in patient biopsies, indicating altered expression and aberrant storage of mutant protein. Kidney biopsy sections from two patients from two different families (MCKD#1 and GCKD#1)  control patient are shown.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14570709","rdfs:label":"Patient Kidney Biopsies","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/98959f99-c8b9-4fe6-af2d-73067b50b58a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2b48fb10-2980-46fe-b5ee-7a39a9ecfea7","type":"Finding","dc:description":"Serum uromodulin is significantly reduced in patients with UMOD mutations and decreases in parallel with a decline in glomerular function, a finding that can be attributed to tubular atrophy rather than reduced glomerular filtration since uromodulin is barely filtered because of its high molecular mass (95 kDa). ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27729211","rdfs:label":"Serum UMOD","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f58a288d-e20e-4cc1-bacc-43a2e05ac5d4","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6eea750a-bcc6-4882-9cec-2b109e65eedd","type":"Finding","dc:description":"Urine uromodulin excretion is reduced in patients.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14570709","rdfs:label":"Urine UMOD levels","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/39233b4e-a491-47b4-8407-2e15dda89221_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ddf1af6a-184e-41ad-a7c2-07127653e913","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0a2493e3-73f9-48ae-aa51-3a719ae305b7","type":"FunctionalAlteration","dc:description":"Western blot performed on cell lysates. Mature protein that has processed along the secretory pathway towards the plasma membrane are glycosylated and therefore have a higher molecular weight. Mutant UMOD that is retained in the ER will not be glycosylated and have a lower molecular weight.  Based upon ER retention, the mutations were subdivided into 4 distinct subgroups.  Class 1 being less severe/higher ratio of glycosylated mature UMOD to Class 4 being more severe with a higher ratio of non-glycosylated UMOD.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32954071","rdfs:label":"In-vitro score"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/bc3d08f9-411d-4e0d-bc7a-28b3481e14ba","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3a7db733-8116-4623-8b11-5e14ccd35187","type":"FunctionalAlteration","dc:description":"AtT-20 cells transfected with UMOD mutations identified in families with inherited kidney disease show aggregation of mutant UMOD in the endoplasmic reticulum. Wild type UMOD is localized to the plasma membrane. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16883323","rdfs:label":"AtT-20 Cell System"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/39233b4e-a491-47b4-8407-2e15dda89221_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ec7cf5bc-7778-4bbd-a5f6-3e62338e6b04","type":"EvidenceLine","dc:description":"Mutation has conflicting information in ClinVar (3 likely pathogenic, 1 uncertain significance).","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/05643d4f-0b54-46b4-ae8b-221f63b95337","type":"Finding","dc:description":"UmodC105F/+ causes myofibroblast proliferation, matrix deposition, and chronic renal failure with aging. Additional observation of C3 immune complex deposits as seen in patient kidney biopsies with the equivalent human UMOD mutation (p.C106F).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32926855","rdfs:label":"UmodC106F/+ mouse ","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/6a0fba14-c079-42ba-bf2d-5e682560b5ca","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/52b57613-8083-4605-a6e7-477f4ab6a279","type":"Finding","dc:description":"Over time, the UmodC147W/+ mice develop increased BUN, serum creatinine, decreased kidney weight.  Urine UMOD was decreased in mutant animals. Tubular damage is seen in biopsies as well as increases in fibrotic disease.  Aggregation in ER is also seen in mutant mice. Further analysis shows this aggregation induces ER stress, cell death, and suppression of autophagic pathways.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28990932","rdfs:label":"UmodC147W/+ mouse ","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":5199,"specifiedBy":"GeneValidityCriteria8","strengthScore":12.7,"subject":{"id":"https://genegraph.clinicalgenome.org/r/JUbuGmsDEEU","type":"GeneValidityProposition","disease":"obo:MONDO_0008264","gene":"hgnc:12559","modeOfInheritance":"obo:HP_0000006"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_39233b4e-a491-47b4-8407-2e15dda89221-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}